• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16524 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     Medical Services Advisory Committee (MSAC) Gefitinib first line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC)
2012     NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab emtansine in combination with pertuzumab for HER2-positive metastatic breast cancer – first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Bortezomib (Velcade) for newly diagnosed mantle cell lymphoma – first line
2012     HAYES, Inc. FlexHD acellular dermis (Musculoskeletal Transplant Foundation) for hernia repair
2012     Agenzia nazionale per i servizi sanitari regionali (Agenas) Renal artery ablation in patients with treatment-resistant hypertension: a systematic review
2012     University of York Evidence briefing on drug treatments for functional class II pulmonary hypertension
2012     Medical Services Advisory Committee (MSAC) Injection of botulinum toxin (Botox) for prophylaxis of headaches in adults with chronic migraine
2012     NIHR Horizon Scanning Centre (NIHR HSC) Obinutuzumab with chlorambucil for chronic lymphocytic leukaemia– first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Hybrid PET/MR systems for whole-body diagnostic imaging
2012     HAYES, Inc. Floseal hemostatic matrix (Baxter Healthcare Corp.) for hemostasis during endoscopic sinus surgery
2012     University of York Evidence briefing on teleconsultation
2012     Medical Services Advisory Committee (MSAC) Testing for HER2 status in gastric cancer for access to trastuzumab
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Generic indicators for process quality in oncological care. A compendium
2012     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for gastrointestinal stromal tumours – second line
2012     NIHR Horizon Scanning Centre (NIHR HSC) SentiMag® and Sienna+® system for sentinel lymph node biopsy in breast cancer
2012     HAYES, Inc. Floseal hemostatic matrix (Baxter Healthcare Corp.) for hemostasis during nephrectomy
2012     Medical Services Advisory Committee (MSAC) Insertion of colonic stents
2012     Basque Office for Health Technology Assessment (OSTEBA) [Indications and recommendations for the use of PET-CT in the planning of radiation oncology treatment. Systematic review]
2012     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for malignant melanoma – first line adjuvant therapy
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: Infrared lasers for treating onychomycosis
2012     HAYES, Inc. Home ultraviolet B phototherapy for psoriasis
2012     Medical Services Advisory Committee (MSAC) Transurethral injection of botulinum toxin into the ladder wall for urinary incontinence due to neurogenic detrusor overactivity
2012     NIHR Horizon Scanning Centre (NIHR HSC) GSK1572932A for non-small cell lung cancer (NSCLC): melanoma-associated antigen 3 (MAGE-A3) positive; stage IB, II or IIIA – adjuvant therapy
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: ThromboLUX™ for determining platelet quality
2012     HAYES, Inc. Low-frequency ultrasound using the mist therapy system (Celleration Inc.) for treatment of wounds
2012     Medical Services Advisory Committee (MSAC) Subcutaneous Immunoglobulins (SCIg)
2012     NIHR Horizon Scanning Centre (NIHR HSC) Genesis™ implantable pulse generator for chronic migraine
2012     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir for chronic hepatitis C infection with compensated liver disease
2012     HAYES, Inc. Meniett low-pressure pulse generator (Medtronic ENT) for treatment of meniere's disease
2012     Medical Services Advisory Committee (MSAC) Percutaneous reconstruction of an insufficient mitral valve through tissue approximation using transvenous/transeptal techniques
2012     Institute for Clinical and Economic Review (ICER) Diagnostic testing for Alzheimer's disease
2012     HAYES, Inc. High-frequency chest wall compression for cystic fibrosis
2012     NIHR Horizon Scanning Centre (NIHR HSC) Simeprevir for chronic hepatitis C infection
2012     HAYES, Inc. NeuraGen nerve guide (Integra LifeSciences Corp.) for repair of severed peripheral nerves of the upper extremity
2012     Medical Services Advisory Committee (MSAC) Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc
2012     Institute for Clinical and Economic Review (ICER) Anti-VEGF treatment options for diabetic macular edema
2012     HAYES, Inc. Human papillomavirus (HPV) genotyping to test for the presence of HPV 16 and 18 in women
2012     NIHR Horizon Scanning Centre (NIHR HSC) Simeprevir for hepatitis C – first line
2012     HAYES, Inc. Osteochondral autograft transplantation (OAT) or mosaicplasty for lesions of the talus (ankle)
2012     Medical Services Advisory Committee (MSAC) Robotic image-guided stereotactic precise beam radiosurgery and radiotherapy for prostate and lung
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bevacizumab for previously treated, human epidermal growth factor receptor2-negative metastatic breast cancer
2012     HAYES, Inc. Hydrogen breath test for irritable bowel syndrome
2012     NIHR Horizon Scanning Centre (NIHR HSC) Nalmefene (Selincro) for the reduction of alcohol consumption – first line pharmacological therapy for alcohol dependence
2012     HAYES, Inc. Panniculectomy for abdominal contouring following massive weight loss
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Appraisal of the quality and accuracy of written consumer health information for patients with chronic myeloid leukaemia on treatment-regimens with dasatinib, imatinib or nilotinib
2012     HAYES, Inc. Interferon-gamma release assays for tuberculosis
2012     NIHR Horizon Scanning Centre (NIHR HSC) GSK-2402968 (Drisapersen) for duchenne muscular dystrophy – first line
2012     HAYES, Inc. Radioactive seed localization (RSL) of nonpalpable breast lesions for surgical excision
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Axitinib for 2nd-line metastatic renal cell carcinoma
2012     HAYES, Inc. Lee Silverman voice treatment for speech and voice problems in parkinson's disease
2012     NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for psoriatic arthritis
2012     HAYES, Inc. Statscan critical imaging system (Lodox Systems (Pty) Ltd.) for evaluation of patients with trauma or injury
2012     HAYES, Inc. Mannitol bronchial provocation challenge for asthma
2012     NIHR Horizon Scanning Centre (NIHR HSC) Secukinumab for moderate to severe, active rheumatoid arthritis
2012     HAYES, Inc. VeinViewer (Christie Digital Systems USA Inc.) for guiding venous access procedures in children
2012     HAYES, Inc. Occipital nerve stimulation for chronic cluster headache and chronic migraine headache
2012     NIHR Horizon Scanning Centre (NIHR HSC) EPI-743 for mitochondrial disease – first line
2012     HAYES, Inc. Negative pressure wound therapy for postsurgical mediastinitis
2012     HAYES, Inc. Mosaicplasty
2012     NIHR Horizon Scanning Centre (NIHR HSC) BIIB-017 for relapsing forms of multiple sclerosis
2012     HAYES, Inc. Negative pressure wound therapy for wounds other than sternal wounds and skin grafts
2012     HAYES, Inc. Palivizumab (Synagis®) prophylaxis for respiratory syncytial virus infection in preterm infants
2012     Adelaide Health Technology Assessment (AHTA) Genetic testing for the diagnosis or prediction of Long QT Syndrome
2012     HAYES, Inc. Negative pressure wound therapy in the adjunct treatment of skin grafts
2012     HAYES, Inc. Percutaneous kyphoplasty
2012     HAYES, Inc. Pharmacokinetically guided dose adjustment of 5-fluorouracil (5-FU)
2012     HAYES, Inc. Percutaneous vertebroplasty
2012     HAYES, Inc. Radiofrequency ablation for sacroiliac joint pain
2012     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for appropriate use of FDG-PET in lung cancer
2012     National Institute for Health and Care Excellence (NICE) PeritX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites. NICE medical technologies guidance 9
2012     HAYES, Inc. Telerehabilitation for musculoskeletal conditions, neuromuscular conditions, and mobility impairment
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: Amniotic fluid lactate™ monitoring system for dysfunctional labour
2012     HAYES, Inc. Recombinant growth hormone treatment for AIDS/HIV-associated wasting and lipodystrophy
2012     HAYES, Inc. Topical antiseptic products for preoperative skin preparation
2012     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for severe asthma
2012     HAYES, Inc. Sialoendoscopy for salivary gland stones
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) The clinical effectiveness and cost of a pneumococcal urine antigen immunochromatographic test (BinaxNOW Streptococcus pneumoniae) in the diagnosis of community acquire Streptococcus pneumoniae pneumonia in patients admitted to hospital
2012     HAYES, Inc. Transcatheter aortic valve implantation for aortic stenosis
2012     NIHR Horizon Scanning Centre (NIHR HSC) Omalizumab for chronic spontaneous urticaria – second line
2012     HAYES, Inc. Vision therapy for dyslexia and other reading and learning disabilities
2012     HAYES, Inc. Ultrasound-guided injections of joints of the extremities
2012     HAYES, Inc. Vitamin D supplementation in patients with osteoporosis
2012     HAYES, Inc. Whole body vibration for the promotion of bone growth in postmenopausal women
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: OVA1™ test for the assessment of suspected ovarian cancer
2012     HAYES, Inc. Complement factor H (CFH) p.Tyr402His and age-related maculopathy susceptibility 2 (ARMS2) p.Ala69Ser polymorphism testing for susceptibility to age-related macular degeneration (AMD)
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: Xpert MTB/RIF® test for tuberculosis
2012     HAYES, Inc. Cytochrome P450 21A2 (CYP21A2) testing in congenital adrenal hyperplasia
2012     Agency for Healthcare Research and Quality (AHRQ) Skin substitutes for treating chronic wounds
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: RealTime mS9 Colorectal Cancer (CRC) Assay for the early detection of colorectal cancer
2012     HAYES, Inc. Factor V (F5) HR2 haplotype testing for hypercoagulability
2012     Agency for Healthcare Research and Quality (AHRQ) Management of asymptomatic carotid stenosis
2012     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) in combination with trastuzumab and chemotherapy for HER2-positive, node-positive or high risk node-negative breast cancer – adjuvant therapy
2012     HAYES, Inc. Factor VII (F7) p.Arg353Gln polymorphism testing
2012     Health Information and Quality Authority (HIQA) Economic evaluation of repeat universal antenatal screening for HIV in the third trimester of pregnancy
2012     NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) with trastuzumab and paclitaxel for HER2 positive locally advanced or metastatic breast cancer – first line
2012     HAYES, Inc. Factor XIIIA1 (F13A1) p.Val34Leu polymorphism testing
2012     NIHR Health Technology Assessment programme Managing Injuries of the Neck Trial (MINT): a randomised controlled trial of treatments for whiplash injuries
2012     NIHR Horizon Scanning Centre (NIHR HSC) Farletuzumab for ovarian cancer: relapsed, platinum-sensitive – in combination with carboplatin and a taxane
2012     HAYES, Inc. KRAS sequence variant analysis for predicting response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in the treatment of non-small cell lung cancer (NSCLC)
2012     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Innovative medical devices for diabetes management